Jugan geon-gang gwa jilbyeong · 2025
[Eighty-four Years of the Masan National Tuberculosis Hospital: The Journey to Eliminate Tuberculosis and New Challenges Ahead].
Аннотация на английскомСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kim Eun-Jin, Jang Woo-Sung, Lee Youn-Jung, Oh Jeong-Eun, Ryoo Sung-Weon, Hwang Soo-Hee
Аннотация
OBJECTIVES: This study highlights the role and significance of the Masan National Tuberculosis Hospital (MNTH), Republic of Korea’s (ROK) first specialized tuberculosis (TB) hospital, by analyzing its 84-year history and key achievements in the context of the National Tuberculosis Control Program.
METHODS: A literature review and analysis of internal reports and documents related to the MNTH’s history and operations were conducted.
RESULTS: The MNTH has focused on managing socioeconomically vulnerable TB patients, including those with multidrug-resistant TB (MDR-TB), the elderly, foreigners, and nonadherent patients. With a specialized medical team and standardized treatment, the MNTH has achieved treatment success rates over 10 percentage points higher than the national average. Through integrated nursing care for severely ill patients, has managed to reduce caregiver burden and economic costs. Additionally, it plays a crucial role in preventing TB transmission through isolation and Directly Observed Treatment, Short-course for nonadherent patients. Leveraging its unique TB specimen bank and biosafety level 3 research facility, the MNTH has made significant contributions to TB research and the development of new diagnostic and therapeutic methods. It also participates in national TB control initiatives, including the “TB Safety Belt” project and regional TB prevention efforts. The MNTH is expanding its role to include national infectious disease response.
CONCLUSIONS: The MNTH is expected to enhance its expertise in MDR-TB treatment, underserved TB patient management, and diagnostic and therapeutic development. Expanding its function as a national infectious disease institution will contribute significantly to ROK’s TB elimination goals and enhance national disease response capabilities.
METHODS: A literature review and analysis of internal reports and documents related to the MNTH’s history and operations were conducted.
RESULTS: The MNTH has focused on managing socioeconomically vulnerable TB patients, including those with multidrug-resistant TB (MDR-TB), the elderly, foreigners, and nonadherent patients. With a specialized medical team and standardized treatment, the MNTH has achieved treatment success rates over 10 percentage points higher than the national average. Through integrated nursing care for severely ill patients, has managed to reduce caregiver burden and economic costs. Additionally, it plays a crucial role in preventing TB transmission through isolation and Directly Observed Treatment, Short-course for nonadherent patients. Leveraging its unique TB specimen bank and biosafety level 3 research facility, the MNTH has made significant contributions to TB research and the development of new diagnostic and therapeutic methods. It also participates in national TB control initiatives, including the “TB Safety Belt” project and regional TB prevention efforts. The MNTH is expanding its role to include national infectious disease response.
CONCLUSIONS: The MNTH is expected to enhance its expertise in MDR-TB treatment, underserved TB patient management, and diagnostic and therapeutic development. Expanding its function as a national infectious disease institution will contribute significantly to ROK’s TB elimination goals and enhance national disease response capabilities.